This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
cannabis: Archive
GrowGeneration (GRWG) Grows Base With 1st Store in New Jersey
by Zacks Equity Research
GrowGeneration (GRWG) launches its first store in New Jersey to widen its reach to 16 states and further strengthen its operations.
NUENegative Net Change BGNegative Net Change IOSPPositive Net Change GRWGNegative Net Change
basic-materials cannabis
Aurora Cannabis (ACB) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Continued strength in Aurora Cannabis' (ACB) domestic adult recreational segment is expected to have driven Q1 sales.
AVEOPositive Net Change ACBNegative Net Change GDRXNegative Net Change
cannabis earnings medical medical-devices
Key Factors to Impact Innovative Industrial (IIPR) Q3 Earnings
by Zacks Equity Research
With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investment in such properties is likely to have aided its Q3 performance, though high expenses might have played a spoilsport.
HSTPositive Net Change PSAPositive Net Change EXRNegative Net Change IIPRPositive Net Change
cannabis reit
GrowGeneration (GRWG) Opens 1st Hydroponic Store in Virginia
by Zacks Equity Research
GrowGeneration (GRWG) opens a new store in Virginia and signs two new leases in New Jersey and Missouri, progressing well on its strategy to grow its retail presence across North America.
SMGPositive Net Change GRWGNegative Net Change GTBIFPositive Net Change CRLBFNegative Net Change
basic-materials cannabis
GrowGeneration (GRWG) Q2 Earnings Miss, Lowers '22 View
by Zacks Equity Research
GrowGeneration (GRWG) reports a drop in Q2 revenues due to the ongoing weakness in the cannabis industry. It lowers revenue guidance to $250 million and $275 million for 2022.
ALBNegative Net Change SQMNegative Net Change CBTNegative Net Change GRWGNegative Net Change
basic-materials cannabis earnings
Jazz's (JAZZ) Q2 Earnings Beat, New Drugs Post Robust Sales
by Zacks Equity Research
JAZZ's Q2 earnings and sales beat expectations on strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals. The company affirms its 2022 guidance.
LLYPositive Net Change JAZZNegative Net Change NVAXNegative Net Change AXSMPositive Net Change
cannabis marijuana
Are Marijuana Stocks A 'Buy' Amid U.S. Decriminalization Bill?
by Bryan Hayes
If signed into law, it would remove marijuana from the Controlled Substances Act (CSA).
MJNegative Net Change CRONNegative Net Change
agriculture cannabis consumer-discretionary e-commerce earnings etfs investing marijuana-stocks medical retail
Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fiscal fourth-quarter results.
GSKPositive Net Change MRKPositive Net Change SGENPositive Net Change TLRYNegative Net Change
cannabis earnings pharmaceuticals
GrowGeneration (GRWG) to Open 1st Hydroponic Store in Mississippi
by Zacks Equity Research
GrowGeneration's (GRWG) new store location will open on June 27, which takes its total number of hydroponic garden store locations to 64 in the United States.
ATINegative Net Change ALBNegative Net Change NTRNegative Net Change GRWGNegative Net Change
basic-materials cannabis
GrowGeneration (GRWG) Q1 Earnings Miss, Trims '22 Outlook
by Zacks Equity Research
GrowGeneration (GRWG) reports a drop in Q1 revenues due to the ongoing weakness in the cannabis industry. It lowers revenue guidance to $340 and $400 million for 2022.
CMCNegative Net Change NTRNegative Net Change GRWGNegative Net Change
basic-materials cannabis earnings